These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22533653)

  • 1. Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC 7 guidelines.
    Krousel-Wood M; Muntner P; Carson A; Anderson AH; Delaune E; Cushman WC; Cutler JA; Piller LB; Goforth GA; Whelton PK
    J Clin Hypertens (Greenwich); 2012 May; 14(5):277-83. PubMed ID: 22533653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of blood pressure reduction response and responder characteristics to fixed-dose combination treatment of amlodipine and losartan: a post hoc analysis of pooled clinical trials.
    Unniachan S; Wu D; Rajagopalan S; Hanson ME; Fujita KP
    J Clin Hypertens (Greenwich); 2014 Sep; 16(9):671-7. PubMed ID: 25098858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
    Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
    Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome.
    Wang JG; Staessen JA; Franklin SS; Fagard R; Gueyffier F
    Hypertension; 2005 May; 45(5):907-13. PubMed ID: 15837826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines.
    Muntner P; Krousel-Wood M; Hyre AD; Stanley E; Cushman WC; Cutler JA; Piller LB; Goforth GA; Whelton PK
    Hypertension; 2009 Apr; 53(4):617-23. PubMed ID: 19221214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
    Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
    Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adult population? Tehran lipid and glucose study (TLGS).
    Azizi F; Rashidi A; Ghanbarian A; Madjid M
    J Hum Hypertens; 2003 Apr; 17(4):287-91. PubMed ID: 12692573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
    Lloyd-Jones DM; Evans JC; Larson MG; O'Donnell CJ; Levy D
    Hypertension; 1999 Sep; 34(3):381-5. PubMed ID: 10489380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial.
    Lu Y; Wang L; Wang H; Gu J; Ma ZJ; Lian Z; Zhang Z; Krumholz H; Sun N
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34580169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
    Itoga NK; Tawfik DS; Montez-Rath ME; Chang TI
    J Am Coll Cardiol; 2021 Oct; 78(17):1671-1678. PubMed ID: 34674811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations.
    Kelly MS; Saseen JJ; Marrs JC
    Ther Adv Cardiovasc Dis; 2017 Feb; 11(2):63-71. PubMed ID: 28033742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension? Messages from ALLHAT, ACCOMPLISH, and ACCORD.
    Giles TD; Houston MC
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):469-71. PubMed ID: 20629806
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) study.
    Petrella RJ; Shlyakhto E; Konradi AO; Berrou JP; Sedefdjian A; Pathak A;
    J Clin Hypertens (Greenwich); 2012 Feb; 14(2):78-84. PubMed ID: 22277139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010.
    Bromfield SG; Bowling CB; Tanner RM; Peralta CA; Odden MC; Oparil S; Muntner P
    J Clin Hypertens (Greenwich); 2014 Apr; 16(4):270-6. PubMed ID: 24621268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.